TERT and glioblastoma: Mutations in the promoter of TERT gene encoding telomerase reverse transcriptase is another strong factor associated with GBM risk, which was frequently observed in GBM especially in adult patients.[60, 61] The role of TERT in GBM oncogenic mechanisms has not been fully understood yet.